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Abstract In tissue engineered heart valves, cell-mediated
stress development during culture results in leaflet retrac-
tion at time of implantation. This tissue retraction is partly
active due to traction forces exerted by the cells and partly
passive due to release of residual stress in the extracellular
matrix and the cells. Within this study, we unraveled the pas-
sive and active contributions of cells and matrix to generated
force and retraction in engineered heart valve tissues. Tissue
engineered rectangular strips, fabricated from PGA/P4HB
scaffolds and seeded with human myofibroblasts, were cul-
tured for 4 weeks, after which the cellular contribution was
changed at different levels. Elimination of the active cellu-
lar traction forces was achieved with Cytochalasin D and
inhibition of the Rho-associated kinase pathway. Both active
and passive cellular contributions were eliminated by lysa-
tion and/or decellularization of the tissue. Maximum cell
activity was reached by increasing the fetal bovine serum
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concentration to 50%. The generated force decreased ∼20%
after elimination of the active cellular component, ∼25%
when the passive cellular component was removed as well
and remained unaffected by increased serum concentrations.
Passive retraction accounted for ∼60% of total retraction,
of which ∼15% was residual stress in the matrix and ∼45%
was passive cell retraction. Cell traction forces accounted for
the remainder ∼40% of the retraction. Full activation of the
cells increased retraction by ∼45%. These results illustrate
the importance of the cells in the process of tissue retraction,
not only actively retracting the tissue, but also in a passive
manner to a large extent.
Keywords Heart valve tissue engineering · Stress gener-
ation · Passive and active retraction · Extracellular matrix ·
Myofibroblasts
1 Introduction
Heart valve tissue engineering is a widely investigated tech-
nology in the field of regenerative medicine as an alterna-
tive for current available heart valve replacements. Tissue
engineered heart valves provide viable implants, which may
have the capacity to grow, remodel, and repair throughout
a patient’s life. For pediatric patients this would prevent
dangerous re-operations throughout their childhood to accom-
modate growth. Over the last decade, bioreactor systems
inducing mechanical conditioning and flow profiles have
improved in vitro tissue formation (Flanagan et al. 2007; Mol
et al. 2005; Kortsmit et al. 2009; Ruel and Lachance 2009;
Syedain and Tranquillo 2009). Moreover, in vivo animal
studies have demonstrated the feasibility of heart valve tissue
engineering, showing remodeling into native-like structures
(Hoerstrup et al. 2000; Sodian et al. 2000; Stock et al. 2000;
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Sutherland et al. 2005; Gottlieb et al. 2010; Schmidt et al.
2010; Flanagan et al. 2009). However, there are still some
challenges that need to be overcome. One of those challenges
is cell-mediated leaflet retraction, causing regurgitation in
vivo (Flanagan et al. 2009; Gottlieb et al. 2010; Syedain et al.
2011). In general, this regurgitation has been neglected and
reported to be only mild. However, it is observed in every
in vivo study and should be considered a serious issue that
needs to be addressed.
Leaflet retraction is a cell-mediated problem, caused by
traction forces that the cells exert on their surroundings. Cells
will always aim to develop an internal stress homeostasis
and adjust their traction forces to retain this in response to
environmental changes (Brown et al. 1998; Mizutani et al.
2004). Increased traction forces are observed upon a decrease
of mechanical loading, while a decrease is observed upon
increased mechanical loading (Brown et al. 1998; Mizutani
et al. 2004). Within the field of heart valve tissue engineer-
ing, the effects of these cell traction forces are controversial.
During constrained tissue culture, the traction forces of the
cells allow them to remodel their surroundings, which results
in compaction of the tissue and the generation of pre-stress
within the extracellular matrix (ECM) (Balestrini and Billiar
2009; Van Vlimmeren et al. 2011). This stress development
within the cells and matrix is beneficial for tissue formation
(Mol et al. 2006) and provides an oriented collagen network
(Robinson et al. 2008; Neidert and Tranquillo 2006). How-
ever, upon release of constraints the developed pre-stress in
the ECM and cells causes immediate retraction of the tis-
sue (passive process), after which the cells start to remodel
their surroundings in an attempt to re-establish their desired
internal stress level (active process), leading to additional
retraction (Balestrini and Billiar 2009). To prevent leaflet
retraction in heart valve tissue engineering, these passive and
active processes need to be unraveled and quantified.
Cell traction forces are transmitted from the intracellular
network of actin fibers to the surrounding ECM via focal
adhesions that consist of complex anchoring proteins, such
as aggregated integrins, vinculin, paxin, tensin, and focal
adhesion kinase (Dugina et al. 2001; Hinz and Gabbiani
2003; Hinz 2006). Intracellular, traction forces are generated
by actin-myosin contraction, which is promoted by phos-
phorylation of myosin light chain (MLC). In myofibroblasts,
this actin-myosin contraction is mediated by the Rho A and
Rho-associated kinase (ROCK) pathway, which blocks MLC
phosphatase and directly phosphorylates MLC (Yee et al.
2001; Nobe et al. 2010; Dallon and Ehrlich 2010; Follonier
Castella et al. 2010). Traction forces can be blocked by the
disruption of actin fibers or inhibition of the ROCK pathway,
and increased by enhancement of the serum concentration
in the culture medium (Grouf et al. 2007; Wakatsuki et al.
2000; Nobe et al. 2010). Blocking traction forces, the active
cellular component of retraction can be eliminated.
Active and passive phenomena have been investigated
thoroughly in short-term studies with fibroblast-populated
collagen and fibrin gel systems (Legant et al. 2009; Marquez
et al. 2009; John et al. 2010; Youssef et al. 2011; Tomasek
et al. 1992; Grouf et al. 2007; Balestrini and Billiar 2009). In
tissue engineered heart valves, the ECM is developed during
4 weeks of tissue culture and is more mature than the gen-
erally investigated collagen and fibrin gels. Tissue retraction
and remodeling is less easy in such a developed tissue, as
the surroundings of the cells are stiffer. Therefore, this study
quantified the passive and active contributions to generated
force and retraction in engineered heart valve tissues. This
was performed in a model system of tissue engineered con-
structs, fabricated from vascular-derived cells seeded onto
a biodegradable scaffold. First, the active cellular traction
forces were eliminated by the disruption of the actin fibers
with Cytochalasin D (CytoD) and the inhibition of the ROCK
pathway by Y-27632. As force and retraction remained sub-
stantial, total cellular contribution (both passive and active)
was eliminated next, by lysation of the cells and decellular-
ization of the tissue. Furthermore, maximum retraction was
investigated by increasing the concentration of serum.
2 Material and methods
2.1 Tissue culture
Human vascular-derived cells were harvested from the vena
saphena magna obtained according to the Dutch guidelines
for secondary used materials. Cells were expanded using
standard cell culture methods in a humidified atmosphere
containing 5% CO2 at 37◦C. Culture medium consisted
of advanced Dulbecco’s Modified Eagle Medium (DMEM;
Invitrogen, Carlsbad, USA), supplemented with 10% Fetal
Bovine Serum (FBS; Greiner Bio one, Frickenhausen, The
Netherlands), 1% GlutaMax (Invitrogen), and 1% penicil-
lin/streptomycin (Lonza, Basel, Switzerland).
Rectangular tissue engineered strips (referred to as TE
constructs) were cultured in a previously described model
system which is shown in Fig. 1a (Van Vlimmeren et al.
2011). Briefly, the TE constructs were cultured in between
two sliding blocks positioned in a metal frame. One of the
sliding blocks was fixed to the metal frame via two leaf
springs and the displacement of this sliding block correlated
to the generated force (Fig. 1b, d). Because the force gener-
ated by the cells during culture deformed the leaf springs, it
was defined as semi-constrained culture. The opposite slid-
ing block was fixated during culture and used to measure
retraction after release of the constraints at the end of the
culture period (Fig. 1c, e).
To fabricate the TE constructs, the cells were seeded
onto rectangular-shaped scaffolds (18 × 5 × 1 mm) of rapid
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Fig. 1 Photographs (a, b, c) and a schematic overview (d, e) of the
model system in which generated force (F, b, d) and retraction (RL ,
c, e) can be measured through the displacement (v) of two sliding
blocks positioned opposite from each other (With permission from
(Van Vlimmeren et al. 2011)). * indicates clamps that can be used to
fix one or both of the sliding blocks. In this study, only the left sliding
block was fixed during culture and the clamp was removed to measure
retraction
degrading nonwoven polyglycolic acid (PGA) (Concordia
Manufacturing Inc., Coventry, RI, USA) coated with poly-4-
hydroxybutyrate (P4HB, received through collaboration with
the University Hospital Zurich) as described previously (Mol
et al. 2005). In summary, the scaffolds were attached to the
two sliding blocks with polyurethane-tetrahydrofuran glue
(15% wt/vol). Sterilization was achieved by 70% ethanol
incubation for 30 min. Cells were seeded at passage 7 with
a seeding density of 15 million cells per cm3 using fibrin as
a cell carrier (Mol et al. 2004). The TE constructs were cul-
tured for 4 weeks. During tissue culture, the medium was sup-
plemented with L-ascorbic acid 2-phosphate (0.25 mg/ml;
Sigma, St. Louis, MO, USA) and replaced twice a week.
2.2 Force generation and retraction
Both force generation and retraction were quantified in Mat-
lab (The MathWorks, Eindhoven, The Netherlands) based
on the displacement of the sliding blocks, using photographs
made underneath a stereomicroscope (Zeiss Observer, Zeiss,
Göttingen, Germany) (Van Vlimmeren et al. 2011). The leaf
springs are an elastic joint, so plastic deformation does not
occur. Every model system was calibrated with its own force-
displacement curve by which force could be quantified with
an error of 8.7%. Retraction was defined as the percentage
of shrinkage compared to the length of the TE construct at
time of release of the constraints.
2.3 Experimental design
After 4 weeks of culture, the generated force was quantified
based on the displacement of the leaf springs compared to
day 0. Changes in force and retraction were compared to
control TE constructs that did not undergo any treatment.
In the first experiment, the active cellular contribution to
the generated force and retraction was investigated (n = 4–8
per group). The TE constructs were incubated 2 h with 50%
FBS to maximize cellular activity, 10 µM cytochalasin D
(Sigma) to disrupt the actin network of the cells, and 10 µM
Y-27632 (Sigma) to inhibit the ROCK pathway. After incuba-
tion with these biochemicals, the change in force was quan-
tified. Next, constraints were released and tissue retraction
was measured during 2 h with time intervals of 15 min. Sub-
sequently, the TE constructs were washed twice with PBS
and received fresh tissue culture medium, except for the FBS
samples which obtained fresh 50% FBS medium. Then, fur-
ther retraction was measured to examine the recovery from
CytoD and the ROCK inhibitor, and maximum retraction in
the FBS group. During the first 8 h, retraction was measured
every 30 min, followed by measurements at 24 and 48 h.
As retraction was still substantial in this first experiment,
we performed a second experiment in which cellular contri-
bution was completely eliminated by lysation of the cells and
complete decellularization of the tissue (n = 5 per group).
Force was again measured before and after treatment, fol-
lowed by retraction measurements. Retraction was measured
every 15 min during the first 2 h, followed by every 30 min
up to 10 h and one final measurement after 24 h.
2.4 Lysation and decellularization
Lysation and decellularization of the TE constructs was per-
formed after 4 weeks of tissue culture. The TE constructs
were washed three times with PBS, after which the cells
were lysated by incubation with a detergent solution (0.25%
triton-X 100 (Merck, Schiphol-rijk, The Netherlands) + 0.25%
sodium-deoxycholate (Sigma) + 0.02% EDTA (Sigma)) over
night at 37◦C. The lysated samples were then washed in
PBS and placed in medium to measure force and retrac-
tion. The decellularized samples were incubated with the
detergent solution as well, after which cellular removal
was established by nuclease treatments with Benzonase
Nuclease (Novagen, EMD Chemicals Inc., San Diego,
USA). The TE constructs were incubated with subsequently
100 U/ml (5–8 h), 80 U/ml (overnight), and 20 U/ml (5–8 h) of
Benzonase in 50 mM TRIS-HCL buffer (Sigma). Finally,
they were washed with PBS and placed in medium to
measure force and retraction.
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2.5 Immunocytochemistry and immunohistochemistry
The effect of 50% FBS, CytoD, and ROCK inhibitor on the
actin network of the cells was evaluated by a whole-mount
F-actin staining (n = 2 per group). In brief, after 2 h of incu-
bation with the biochemicals, the TE constructs were washed
three times with PBS for 5 min, followed by fixation with
3.7% formaldehyde (Merck) for 40 min. Next, samples were
permeabilized with 0.5% Triton-X 100 (Merck) for 30 min.
Subsequently, the TE constructs were incubated with Phalloi-
din-TRITC (1:500, Sigma) for 60 min, after which they were
washed 3 times with PBS for 5 min. Finally, the TE constructs
were incubated with 4′,6-diamidino-2-phenylindole (DAPI)
for 15 min, washed three times with PBS for 5 min, and evalu-
ated using a multiphoton microscope (Zeiss LSM 510 META
NLO, Darmstadt, Germany) in Two-Photon-LSM mode.
The efficacy of cellular lysation and tissue decellulariza-
tion was evaluated qualitatively by histological and immuno-
fluorescent stainings (n = 1 per group). The TE constructs
were fixated with 3.7% formaldehyde (Merck), embedded
in paraffin, and cut in tissue sections of 10 μm. Samples
were studied by hematoxylin and eosin (HE) staining for gen-
eral tissue morphology and cellular content. Further, a DAPI
staining was performed to check the presence or absence
of cell nuclei. The HE staining was visualized using light
microscopy (Axio Observer, Zeiss, Göttingen, Germany) and
the DAPI staining was evaluated using fluorescence micros-
copy (Axiovert 200M, Zeiss, Göttingen, Germany).
2.6 Biochemical composition of tissues
The amount of DNA was assessed from all samples (n = 56).
In control, lysated, and decellularized samples, the amount
of sulfated glycosaminoglycans (GAGs) and collagen was
determined as well to investigate the effect of lysation and
decellularization on the ECM composition (n = 4 per group).
Lyophilized tissue samples were digested in papain solution
(100 mM phosphate buffer, 5 mM L-cysteine, 5 mM ethyl-
enediaminetetraacetic acid (EDTA), and 125–140µg papain
per ml) at 60◦C for 16 h. DNA content was determined with
the Hoechst dye method (Cesarone et al. 1979) and a stan-
dard curve of calf thymus DNA (Sigma). GAG content was
determined with a modification of the assay described by
Farndale et al. (1986) and a standard curve from chondroitin
sulfate from shark cartilage (Sigma). In short, 40 µl of diluted
sample, without addition of chondroitin AC lyase, chondroi-
tin ABC lyase, and keratanase, was pipetted into a 96-well
plate in duplicate. Subsequently, 150 µl dimethylmethylene
blue was added and absorbance was measured at 540 nm.
The hydroxyproline content was determined with an assay
according to Huszar et al. (1980) and a reference of trans-4-
hydroxyproline (Sigma). A 1-to-8.9 ratio of hydroxyproline
to collagen was assumed.
2.7 Statistical analyses
All data are presented as mean and their standard error
of mean. One-way ANOVA, followed by a Tukey’s multi-
ple comparison post hoc test, was carried out to evaluate
statistical differences. Statistical analyses were done using
GraphPad Prism software (GraphPad Software, Inc, USA)
and considered significant for P values <0.05.
3 Results
3.1 The effect of 50% FBS, Cytochalasin D, and ROCK
inhibitor on force and retraction
Figure 2 gives an overview of representative immuno-
fluorescent stainings of the actin fibers within the cells
at 14 and 28 µm tissue depths. Both control and FBS
samples contained aligned and organized actin fibers. Incu-
bation with CytoD disrupted the actin network. In the superfi-
cial surface layer (14 µm), cells became completely rounded,
while stretched cells with a fragmented actin network were
observed deeper in the tissue (28 µm). Incubation with
ROCK inhibitor was less destructive for the actin network
than CytoD. The actin network became less organized, but
individual fibers could still be observed.
Figure 3 and Table 1 provide an overview of the force mea-
sured before (pre) and after (post) incubation with the bio-
chemicals, and the absolute and relative change. On average,
generated force after 4 weeks of culture was 39.4 ± 2.3 mN.
Incubation with FBS for 2 h had no effect on the generated
force within the TE constructs, while incubation with CytoD
and ROCK inhibitor significantly decreased the generated
force by 7.7±0.7 and 6.8±0.5 mN, respectively. There was
no difference in the effect of treatment between CytoD or
ROCK inhibitor, both reduced force by approximately 20%.
DNA content was similar in all groups, so cell density could
not have caused differences in the generated force or changes
to it (data not shown).
Retraction after release of the constraints occurred rap-
idly during the first 30 min, after which it slowly contin-
ued (Fig. 5a). After 2 h, retraction was higher in the FBS
group than in the control samples. Incubation with CytoD
and ROCK inhibitor decreased the amount of retraction com-
pared to control samples. There was no significant difference
between incubation with ROCK inhibitor or CytoD (Fig. 4b).
An overview of the absolute retraction values is given in
Table 1.
Retraction of the FBS samples remained higher up to 10 h,
but after 24 h, retraction in control samples reached a similar
level (Fig. 5). Two hours after refreshment of the medium,
the ROCK inhibitor and CytoD samples started to recover.
Recovery seemed faster in the ROCK inhibitor samples than
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Fig. 2 Immunofluorescent stainings visualizing actin fibers (red) and
cell nuclei (blue) in constrained control samples (a, b) and constrained
samples treated with 50% FBS (c, d), CytoD (e, f) and ROCK inhibitor
(g, h) for 2 h. Control and FBS samples show aligned and organized
fiber structures. Cells treated with CytoD become rounded at the sur-
face layer and show a fragmented network at 28µm. ROCK inhibitor
causes a slight disruption of the actin fiber organization. The white bar
represents 50µm
Table 1 Absolute and relative force and retraction
Force change Retraction (%)
Absolute (mN) Relative (%) 2 h % Control 2 h 10 h 24 h 48 h
Control −1.1 ± 0.3 −2.8 ± 0.6 24.2 ± 1.8 100.0 ± 7.7 36.6 ± 3.2 42.4 ± 5.7 46.2 ± 6.6
FBS 2h +0.7 ± 0.8 +1.1 ± 2.4 35.5 ± 2.4* 146.6 ± 10.0* 49.5 ± 1.1* 51.7 ± 1.8 53.4 ± 1.9
CytoD 2h −7.7 ± 0.7** −20.1 ± 1.9** 14.8 ± 1.3* 61.0 ± 5.4* 27.9 ± 4.5 34.4 ± 5.9 47.2 ± 5.5
ROCK 2h −6.8 ± 0.5** −21.0 ± 3.2** 14.7 ± 1.0* 60.7 ± 4.0* 31.7 ± 1.5 43.9 ± 6.4 61.4 ± 4.9
Control +0.1 ± 0.6 +0.2 ± 1.6 24.2 ± 1.9 100.0 ± 7.7 30.9 ± 2.4 34.0 ± 2.7
Lysated −12.9 ± 1.9** −27.3 ± 3.4** 4.2 ± 0.7** 17.5 ± 2.7** 4.3 ± 0.8** 5.1 ± 0.9**
Decellularized −9.5 ± 1.3* −25.4 ± 2.7* 3.7 ± 0.3** 15.2 ± 1.3** 5.9 ± 0.6** 5.9 ± 0.5**
*, ** Significant difference of, respectively, p < 0.05 and p < 0.001 compared to control samples
in the CytoD samples. After 8 h, retraction was no longer
significantly lower than in the control samples.
3.2 The effect of cell lysation and decellularization on force
and retraction
In the lysated constructs, the amount of DNA was similar
to the control samples (Fig. 6a). The DAPI and HE stainings
confirmed the presence of cells (Fig. 6e, h, k). Decellularized
constructs contained hardly any detectable DNA (Fig. 6a),
which was confirmed in the staining by the absence of cell
nuclei in the DAPI staining and cells in the HE staining
(Fig. 6f, i, l). The amount of collagen remained unaffected
by both lysation and decellularization (Fig. 6f, i, l). There
was a significant decrease in GAGs of both lysated and de-
cellularized constructs compared to controls (Fig. 6c). This
decrease was larger in the decellularized samples than in the
lysated samples.
Lysation and decellularization decreased the generated
force by 12.9 ± 1.9 and 9.8 ± 1.2 mN, respectively (Fig. 7;
Table 1). There was no difference between the effects of lysa-
tion and decellularization on the generated force. The relative
decreases compared to the force before lysation and decellu-
larization were, respectively, 27.3 ± 3.4% and 25.4 ± 2.7%.
At release of constraints, retraction in the lysated and
decellularized samples was substantially lower than in the
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Fig. 3 Generated force in control samples (a) and before (pre) and after
(post) incubation with 50% FBS (b), CytoD (c), and ROCK inhibitor
(d). e Change in force relative to the generated force before addition of
the biochemicals. Force remained constant in samples treated with 50%
FBS and decreased in samples treated with CytoD and ROCK inhibitor.
** Significant difference of p < 0.001 to control samples
control samples at 2, 10, and 24 h (Fig. 8). Retraction in the
lysated and decellularized samples occurred in the first
30 min, after which they remained stable, while control sam-
ples kept on retracting (Fig. 8). An overview of the absolute
retraction values is given in Table 1.
4 Discussion
Cell-mediated compaction and retraction are general occur-
ring phenomena in tissue engineering, mainly observed and
investigated in fibrin and collagen gel systems. Within heart
valve tissue engineering, cell traction forces lead to leaflet
shrinkage, which, in vivo, results in regurgitation. The dif-
ference between an autologous tissue engineered heart valve
and the generally investigated gel systems is the presence
of a biodegradable synthetic scaffold in the beginning of the
culture period and a well-developed ECM that is synthesized
by the cells after 4 weeks of tissue culture. As these two
aspects complicate tissue retraction, thorough investigation
of the problem is needed, before it can be solved. Previously,
we have quantified the generation of force, stress, compac-
tion, and retraction over time, and observed that the scaffold
is able to resist the traction forces of the cells during the
first 2 weeks. After 4 weeks of tissue culture, the scaffold is
degraded and it was observed that a fully developed tissue
compacts and retracts significantly, but less than the gel sys-
tems do (Van Vlimmeren et al. 2011). In this study, we aimed
to quantify the contribution of the cells, as retraction is a
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Fig. 4 a Tissue retraction during 2 h after release of constraints. b After 2 h, retraction was higher in the FBS samples and lower in CytoD and
ROCK inhibitor samples compared to the control samples. * Significant difference of p < 0.05 to control samples
Fig. 5 a Tissue retraction and recovery from biochemicals over time.
b After 8 h of recovery, retraction of CytoD and ROCK inhibitor sam-
ples was similar to control samples, while retraction of FBS samples
was higher than control samples. At 24 and 48 h, retraction was similar
in all samples. * Significant difference of p < 0.05 to control samples
cell-mediated problem. Therefore, we distinguished passive
from active contributions to generated force and retraction,
by changing traction forces.
4.1 Passive and active components in force generation
The generated forces measured within these experiments
ranged from 20 to 60 mN. In previous experiments, this range
of generated forces was also observed and we believe that it
is caused by the natural biological variability of the TE con-
structs. As the net force is determined by both the mechanical
integrity of the ECM and the force that the cells exert to it, it
is not possible to ascribe this variability to one single tissue
component. The ECM integrity is affected by the amount of
collagen, collagen cross-links, and the organization of this
fibrous network. Next to this, the number of cells that exert
traction forces will affect the net force measured within the
system.
Increasing the FBS concentration from 10 to 50% did not
affect the generated force. It was predicted that increasing
the FBS concentration would increase the generated force,
as this was shown when increasing the FBS concentration
from 0–10 to 20% (Yee et al. 2001; Wakatsuki et al. 2000).
FBS contains many growth factors, from which transform-
ing growth factor-β (TGF-β) is one that is known to induce
cell traction forces (Wipff and Hinz 2009; Hinz 2006; Brown
et al. 2002). Although TGF-β probably is not the only growth
factor in FBS that induces increased traction forces, for this
particular growth factor it has been shown that there is an
optimum working concentration between 7.5 and 15 ng/ml.
Concentrations above this optimum decreased the generated
force (Brown et al. 2002). 50% FBS could be above this
optimum, but as it did increase tissue retraction, as discussed
later, this is unlikely. More likely, at week 4 the ECM is
strong enough to withstand the traction forces. In this case, a
small increase in traction forces, due to increased FBS con-
centrations, will not affect the deformation much. However,
when constraints are released, the organization of the ECM
may be affected and it might loose its mechanical integrity.
This would mean that the samples will be more prone to the
increased traction forces and thus increased retraction might
occur.
Incubation with CytoD or ROCK inhibitor decreased the
generated force by ∼20% compared to control samples.
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Fig. 6 DNA (a), collagen (b), and GAG (c) content, and DAPI
(d–f) and HE (g–l) staining of control, lysated, and decellularized
TE constructs. In the control and lysated samples, cells were present
(small, dark dots indicated by the white arrows). In the decellularized
constructs, cells were absent. GAG content decreased in lysated and
decellularized samples. The black arrows indicate scaffold remnants.
** Significant difference of p < 0.001 to control samples. # Signifi-
cant difference of p < 0.05. The white bars represent 200µm
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Fig. 7 Generated force in control samples (a) and before (pre) and after
(post) lysation (b) and decellularization (c). d Change in force relative
to the generated force before addition lysation and decellularization.
Force decreased in the lysated and decellularized samples compared to
the control samples. ** Significant difference of p < 0.001 to control
samples
Although CytoD disrupts the complete actin network and
ROCK inhibitor only inhibits myosin-actin contraction, there
was no difference between the two treatments in gener-
ated force. The actin fiber network of the CytoD treated
samples was fragmented compared to the ROCK inhibitor
samples, where individual fibers were still present. To vali-
date the elimination of cellular traction forces, we incubated
TE constructs with CytoD for 16 h, but this did not change the
decrease in force (data not shown). These results suggest that
how the cellular traction forces are eliminated is functionally
indistinguishable. Next, we lysated and decellularized the TE
constructs to eliminate potential remaining passive cell con-
tributions. The resulting decrease in force was ∼26% and did
not differ from the CytoD and ROCK inhibitor samples. In
literature, the reported active and passive cellular contribu-
tions to generated force are much higher. The active cellu-
lar contribution to force of fibroblasts in collagen gels was
35–65% (Marquez et al. 2009; Youssef et al. 2011; John et al.
2010; Legant et al. 2009) and lysation caused an additional
30% reduction of force below the level observed with CytoD
treatment (Wakatsuki et al. 2000). To measure a decrease in
force within our model system, bending of the leaf springs
must become less and this requires elongation of the TE con-
structs. The 20–25% decrease in force that was measured
required an elongation of 400–500μm. As cells have remod-
eled the ECM to a certain length, the collagen fibers form
an entangled network at that length and relaxation can only
occur up to a maximum. The 20–25% decrease in force that
we obtained is closest to the observation of John et al., who
observed a decrease of ∼35% after incubation with CytoD
in a set-up that also used bending beams.
4.2 Passive and active components in tissue retraction
Two hours after release of constraints, retraction in the FBS
samples was∼45% higher than in the control samples. CytoD
or ROCK inhibitor decreased retraction by ∼40% compared
to control samples, and lysation and decellularization of the
samples decreased retraction by ∼85%. We have summa-
rized these results in Fig. 9, illustrating activated retraction
and a subdivision of normal retraction into active and passive
components.
The decreases in retraction observed after treatment with
CyotD and ROCK inhibitor or after lysation and decellular-
ization are much greater than the decreases in the generated
force. We believe that this is due to the relative weak leaf
springs that were used in the model system. As mentioned
in the previous section, a decrease in force requires an elon-
gation of the tissue engineered construct, which is difficult
as the ECM has been remodeled to a certain length. If the
leaf springs would be stiffer, the required elongation would
be minimal, which might result in a larger decrease of force
after the treatment.
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Fig. 8 a Tissue retraction during 24 h after release of constraints.
b Retraction after 2, 10, and 24 h was less in the lysated and decellular-
ized samples compared to control samples. ** Significant difference of
p < 0.001 to control samples
FBS increased tissue retraction by 45%. The growth
factor TGF-β, which we previously indicated to regulate
traction forces of the cells, has also shown to increase retrac-
tion (Grouf et al. 2007). As in vivo plasma levels reach 55% of
serum, this increased retraction is important for the in vivo
response of the cells after implantation. The high plasma
level in vivo is likely to enhance cellular traction forces and
retraction. However, in the end this will not result in more
retraction in vivo as retraction of control samples reached
similar levels as the FBS samples after 24 h in vitro, most
likely caused by volume restrictions.
In fibroblast seeded fibrin gels, active retraction accounted
for ∼75% of the total retraction (Grouf et al. 2007; Balestrini
and Billiar 2009) and in collagen gels seeded with fibroblasts,
this was ∼80% (Tomasek et al. 1992). Based on this litera-
ture, the active retraction in the TE constructs was less than
expected. 16 h of incubation with CytoD, to check the elimi-
nation of traction forces, did not change retraction compared
to 2 h of incubation (data not shown). Therefore, we elimi-
nated passive cellular contributions as well by lysation and
decellularization. Although passive cell behavior has been
reported by others (Roy et al. 2009; Wakatsuki et al. 2000),
it was not expected to contribute for 45% to retraction. In por-
cine arteries, elongation increased from 12 to 20% between
CytoD treatment and decellularization (Roy et al. 2009).
Passive contribution might arise from release of residual
stress in the cells that form connections between fibers within
the matrix or the space-occupying properties of the cells
(Wakatsuki et al. 2000). However, both require that the cells
remain elongated and connected to the ECM. For both ROCK
inhibition and CytoD treatment, it was indeed shown that
cells become irregular in shape, but retain their elongated
cell configuration in this and other studies (Tomasek and
Hay 1984; Tamariz and Grinnell 2002). The absence of dif-
ferences between lysated and decellularized samples demon-
strated that the presence of cellular material does not affect
retraction once cells are lysated.
The residual stress within the ECM accounted for 15% of
total retraction. This residual stress is likely developed dur-
ing ECM remodeling of the cells, in which collagen fibers
are re-organized and cross-links are formed. Cell lysation and
decellularization decreased the amount of GAGs. As we have
previously found that increased GAG content decreased the
amount of retraction (unpublished data), the passive retrac-
tion of the ECM could have been overestimated in this study
and partly be caused by the decrease in GAGs.
Fig. 9 Illustration of active and
passive cell retraction, passive
ECM retraction, and activated
cell retraction in TE constructs.
Active cell retraction accounts
for ∼40% of total retraction,
passive cell retraction accounts
for ∼45% of total retraction,
and passive residual stress in the
ECM accounts for ∼15%.
Finally, activated cells increase
retraction by 45%
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4.3 Implications for heart valve tissue engineering
We hypothesized that temporarily decreasing cellular trac-
tion forces at time of implantation might solve the problem
of retraction. The results presented in this study demonstrate
that this hypothesis does not hold. When eliminating the trac-
tion forces of the cells the TE constructs still retracted up to
15% within 2 h. The hypothesis was based on the idea that
loads applied during the cardiac cycle might be able to coun-
terbalance the recovered traction forces once the valve is
functioning in vivo. Maximum loading only occurs a very
brief period every heart cycle, and further studies are needed
to investigate whether this loading is enough to resist the con-
tinuous presence of the traction forces. As soon as the valve
is implanted, cellular traction forces will recover. Recovery
from CytoD and ROCK at 20% FBS occurred within 8 h
and in vivo this will likely be faster due to higher serum
concentrations. A recent study of Seydain et al. confirms
these expectations (Syedain et al. 2011). They treated fibrin-
based tissue engineered heart valves with blebbistatin before
implantation to decrease retraction. At implantation, these
valves were functional, but after 4 weeks, regurgitation was
moderate and at week 8 only one shortened leaflet was pres-
ent. Minimizing cell vitality by treatment with sodium azide
gave similar results, probably caused by proliferation of the
remaining cells. These findings indicate that the cells become
active again once they are implanted in vivo.
Decellularization or lysation reduced retraction to ∼4%.
Although this is still a lot, it is easier to correct for in the
design of the heart valve as retraction occurs immediately
upon release of constraints and remains stable after that.
Implantation of a decellularized valve would represent a dif-
ferent approach, as it would require seeding of new non-con-
tractile cells or the attraction of endogenous cells in vivo to
ensure a viable implant. It is, however, a promising approach
as decellularized valves have already shown functionality in
vivo (Simon et al. 2003; Cebotari et al. 2006; Erdbrugger
et al. 2006; Hopkins et al. 2009) and it is currently under
investigation for tissue engineered constructs as well (Dahl
et al. 2011).
5 Conclusion
The active cellular contribution to the generated force after
4 weeks is at least 20%. Passive retraction accounted for 60%
of total retraction, of which 15% was residual stress in the
ECM and 45% was passive cell retraction. Cellular traction
forces account for the remainder of the retraction (40%).
These results indicate that the passive cell contribution to
retraction should not be underestimated. Interpretation of
passive cell retraction is difficult, as the effect of the bio-
chemicals on the interaction between the cell and the matrix
is uncertain. Further studies should focus on unraveling the
basis of the passive cell retraction for fundamental under-
standing of the mechanism behind this phenomenon. Ideally,
one would like to bypass the passive cell contribution, with-
out lysation of the cells to maintain a viable implant. The
residual stress in the ECM is small and might be overcome
by design changes to the tissue engineered heart valve geom-
etry. These results provide valuable insights into the passive
and active components of tissue retraction and are crucial for
solving leaflet retraction in heart valve tissue engineering.
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